FDC Ltd (FDC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 248455, "name": "FDC", "stock_name": "FDC", "full_name": "FDC Ltd", "name_url": "stocks-analysis/fdc", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "389.35", "chg": 5.5, "chgp": "1.43%", "dir": 1, "prev_price": "383.85", "mcapval": "6,244.00 Cr", "mcap": "Small Cap", "scripcode": 531599, "symbol": "FDC", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE258B01022", "curr_date": "Jun 19, 03:30 PM", "curr_time": "22:56 PM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "1.46 lacs", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fdc-248455-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "FDC Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-sell-by-marketsmojo-4052872", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FDCLtd_mojoScore_4052872.png", "date": "2026-06-14 10:10:04", "description": "FDC Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "FDC Ltd Valuation Shifts to Fair Amidst Sector Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-to-fair-amidst-sector-volatility-4036712", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FDCLtd_valuationdot_4036712.png", "date": "2026-06-08 08:00:19", "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite a recent 5.04% decline in its share price to ₹380.75 on 8 June 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest improved price attractiveness relative to its historical and peer averages. This article analyses the valuation changes, compares FDC’s metrics with sector peers, and assesses the implications for investors amid a challenging market backdrop." }, { "title": "FDC Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-sell-4033681", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FDCLtd_mojoScore_4033681.png", "date": "2026-06-03 10:10:03", "description": "FDC Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "FDC Ltd Valuation Shifts to Fair Amidst Sector Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-to-fair-amidst-sector-volatility-4029072", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FDCLtd_valuationdot_4029072.png", "date": "2026-06-02 08:00:53", "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters improve from expensive to fair, signalling a notable shift in price attractiveness. Despite a recent day decline of 1.7%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more balanced investment proposition compared to its historically stretched multiples and peer group benchmarks." }, { "title": "FDC Ltd Gains 8.09%: 3 Key Factors Driving This Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-gains-809-3-key-factors-driving-this-weeks-volatility-4024502", "imagepath": "", "date": "2026-05-31 12:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock dips 0.92% amid broad market rally</p>\n <p><strong>26 May:</strong> Intraday high of Rs.404 with a 10.69% surge</p>\n <p><strong>27 May:</strong> Strong quarterly results announced, stock rises 5.91%</p>\n <p><strong>29 May:</strong> Profit-taking leads to 5.60% decline, week closes at Rs.403.60</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.373.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.403.60</..." }, { "title": "FDC Ltd Reports Strong Quarterly Turnaround Amid Positive Financial Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-reports-strong-quarterly-turnaround-amid-positive-financial-trend-4019097", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FDCLtd_fintrenddot_4019097.png", "date": "2026-05-29 08:00:12", "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable financial turnaround in the quarter ended March 2026. After a period of negative trends, the company’s recent quarterly results reveal significant growth in profitability metrics, signalling a positive shift in its financial trajectory despite lingering concerns over non-operating income contributions." }, { "title": "Are FDC Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-fdc-ltd-latest-results-good-or-bad-4018932", "imagepath": "", "date": "2026-05-28 19:21:46", "description": "FDC Ltd's latest financial results for Q4 FY26 present a complex picture. The company reported a net profit of ₹103.40 crore, reflecting a significant year-on-year growth of 167.39%. Revenue for the same quarter reached ₹584.79 crore, marking an 18.89% increase compared to the previous year. The operating margin improved to 18.19%, up from 10.97% in Q4 FY25, indicating a positive trend in operational efficiency.\n\nHowever, the results also reveal underlying concerns. A notable portion of the profit, ₹49.89 crore, came from other income, which constituted 35.55% of profit before tax, raising questions about the sustainability of core business profitability. The reliance on non-operating income suggests potential vulnerabilities in the company's operational performance.\n\nThe quarterly performance exhibited significant volatility, with revenue growth of 25.84% sequentially from the previous quarter, contrasting..." }, { "title": "FDC Q4 FY26: Stellar Quarter Masks Underlying Profitability Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/fdc-q4-fy26-stellar-quarter-masks-underlying-profitability-concerns-4017834", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FDC_quaterlyResult_4017834.png", "date": "2026-05-27 22:30:33", "description": "FDC Ltd., a fully integrated pharmaceutical company specialising in formulations and active pharmaceutical ingredients, reported a remarkable turnaround in Q4 FY26 with consolidated net profit surging 167.39% year-on-year to ₹103.40 crores, compared to ₹38.67 crores in Q4 FY25. The quarter-on-quarter performance was even more dramatic, with profits jumping 265.37% from ₹28.30 crores in Q3 FY26. Despite this impressive headline performance, the stock has struggled over the past year, declining 6.95%, whilst the broader pharmaceuticals sector gained 11.45%. The company, with a market capitalisation of ₹6,692 crores, trades at a P/E multiple of 30x, reflecting investor concerns about sustainability of earnings and margin volatility." }, { "title": "FDC Ltd Surges 10.7% to Day's High of Rs 404 — Outperforms Sector by 8.7 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-hits-intraday-high-with-1069-surge-on-26-may-2026-4013797", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FDCLtd_priceRelatedfactors_4013797.png", "date": "2026-05-26 13:01:17", "description": "The Sensex declined 0.25% on 26 May 2026, while FDC Ltd surged 10.69%, marking a striking 8.66-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which touched an intraday high of Rs 404, up 9.2% from its previous close." } ], "total": 243, "sid": "248455", "stock_news_url": "https://www.marketsmojo.com/news/fdc-248455" }, "announcements": [ { "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulation 2015", "datetime": "04-Jun-2026", "details": "Announcement under Regulation 30 of SEBI (LODR) Regulation 2015", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)", "datetime": "28-May-2026", "details": "This is with regards to our intimation made on May 27 2026 for Press Release wherein there was typographical error in the Subject line of Press Release in the mentioned year which shall be read as Press release on Q4 - FY 2025-26 and 12 M - FY 2025-26 Results.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot", "datetime": "28-May-2026", "details": "Please find attached the outcome of Postal Ballot", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "FDC Ltd has declared <strong>500%</strong> dividend, ex-date: 11 Feb 26", "dt": "2026-02-11", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Stock dips 0.92% amid broad market rally

26 May: Intraday high of Rs.404 with a 10.69% surge

27 May: Strong quarterly results announced, stock rises 5.91%

29 May: Profit-taking leads to 5.60% decline, week closes at Rs.403.60

Week Open

Rs.373.40

Week Close

Rs.403.60Read full news article

FDC Ltd Reports Strong Quarterly Turnaround Amid Positive Financial Trend

2026-05-29 08:00:12

FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable financial turnaround in the quarter ended March 2026. After a period of negative trends, the company’s recent quarterly results reveal significant growth in profitability metrics, signalling a positive shift in its financial trajectory despite lingering concerns over non-operating income contributions.

Read full news article

Are FDC Ltd latest results good or bad?

2026-05-28 19:21:46

FDC Ltd's latest financial results for Q4 FY26 present a complex picture. The company reported a net profit of ₹103.40 crore, reflecting a significant year-on-year growth of 167.39%. Revenue for the same quarter reached ₹584.79 crore, marking an 18.89% increase compared to the previous year. The operating margin improved to 18.19%, up from 10.97% in Q4 FY25, indicating a positive trend in operational efficiency. However, the results also reveal underlying concerns. A notable portion of the profit, ₹49.89 crore, came from other income, which constituted 35.55% of profit before tax, raising questions about the sustainability of core business profitability. The reliance on non-operating income suggests potential vulnerabilities in the company's operational performance. The quarterly performance exhibited significant volatility, with revenue growth of 25.84% sequentially from the previous quarter, contrasting...

Read full news article

FDC Q4 FY26: Stellar Quarter Masks Underlying Profitability Concerns

2026-05-27 22:30:33

FDC Ltd., a fully integrated pharmaceutical company specialising in formulations and active pharmaceutical ingredients, reported a remarkable turnaround in Q4 FY26 with consolidated net profit surging 167.39% year-on-year to ₹103.40 crores, compared to ₹38.67 crores in Q4 FY25. The quarter-on-quarter performance was even more dramatic, with profits jumping 265.37% from ₹28.30 crores in Q3 FY26. Despite this impressive headline performance, the stock has struggled over the past year, declining 6.95%, whilst the broader pharmaceuticals sector gained 11.45%. The company, with a market capitalisation of ₹6,692 crores, trades at a P/E multiple of 30x, reflecting investor concerns about sustainability of earnings and margin volatility.

Read full news article

FDC Ltd Surges 10.7% to Day's High of Rs 404 — Outperforms Sector by 8.7 Percentage Points

2026-05-26 13:01:17

The Sensex declined 0.25% on 26 May 2026, while FDC Ltd surged 10.69%, marking a striking 8.66-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which touched an intraday high of Rs 404, up 9.2% from its previous close.

Read full news article